Taro Pharmaceutical Industries Shares Outstanding 2006-2019 | TARO

Taro Pharmaceutical Industries shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Taro Pharmaceutical Industries Annual Shares Outstanding
(Millions of Shares)
2019 39
2018 40
2017 41
2016 43
2015 43
2014 44
2013 45
2012 44
2011
2011 41
2010
2010 41
2009 40
2008 35
2007 30
2006
2006
2005 30
Taro Pharmaceutical Industries Quarterly Shares Outstanding
(Millions of Shares)
Q4 2019 39
Q3 2018 39
Q2 2018 39
Q1 2018 39
Q4 2018 40
Q3 2017 40
Q2 2017 40
Q1 2017 40
Q4 2017 41
Q3 2016 41
Q2 2016 41
Q1 2016 42
Q4 2016 43
Q3 2015 43
Q2 2015 43
Q1 2015 43
Q4 2015 43
Q3 2014 43
Q2 2014 43
Q1 2014 43
Q4 2014 43
Q3 2013 45
Q2 2013 45
Q1 2013 45
Q4 2013 45
Q3 2012 45
Q2 2012 45
Q1 2012 45
Q4 2012 45
Q3 2011 45
Q2 2011 45
Q1 2011 45
Q4 2011 44
Q3 2010 40
Q2 2010 41
Q1 2010 41
Q4 2010 41
Q3 2009
Q2 2009 41
Q1 2009 41
Q4 2009
Q3 2008 40
Q2 2008 40
Q3 2007
Q3 2006
Q4 2006
Q3 2005
Q2 2005 30
Q1 2005 30
Q4 2005 30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.187B $0.670B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.495B 35.46
Astellas Pharma (ALPMY) Japan $28.364B 13.91
Takeda Pharmaceutical (TAK) Japan $26.810B 7.87
UCB SA (UCBJF) Belgium $15.866B 0.00
Eisai (ESALY) Japan $15.587B 26.80
Grifols, S.A (GRFS) Spain $15.360B 19.43
Merck (MKGAF) Germany $13.803B 18.84
IPSEN SA ADR (IPSEY) France $10.823B 0.00
Ionis Pharmaceuticals (IONS) United States $9.665B 21.13
Sage Therapeutics (SAGE) United States $9.265B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Catalent (CTLT) United States $8.006B 32.13
Neurocrine Biosciences (NBIX) United States $7.926B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.569B 10.38
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.637B 9.19
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.829B 16.97
Evotec AG (EVTCY) Germany $4.364B 46.84
FibroGen (FGEN) United States $4.115B 0.00
Tilray (TLRY) Canada $4.103B 0.00
United Therapeutics (UTHR) United States $3.279B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.843B 428.29
PTC Therapeutics (PTCT) United States $2.582B 0.00
Xencor (XNCR) United States $2.503B 68.34
Zogenix (ZGNX) United States $2.041B 0.00
Portola Pharmaceuticals (PTLA) United States $1.819B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.695B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.637B 79.28
Enanta Pharmaceuticals (ENTA) United States $1.623B 22.17
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.466B 12.74
Heron Therapeutics (HRTX) United States $1.440B 0.00
Corcept Therapeutics (CORT) United States $1.261B 18.00
ArQule (ARQL) United States $1.196B 0.00
Aerie Pharmaceuticals (AERI) United States $1.029B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.027B 3.70
Theravance Biopharma (TBPH) Cayman Islands $1.016B 0.00
Radius Health (RDUS) United States $1.006B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.857B 0.00
Concordia (CXRXF) Canada $0.716B 0.00
Endo (ENDP) Ireland $0.710B 1.14
Aptorum Group (APM) China $0.648B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.570B 0.00
Organogenesis Holdings (ORGO) United States $0.539B 0.00
TherapeuticsMD (TXMD) United States $0.536B 0.00
Karyopharm Therapeutics (KPTI) United States $0.507B 0.00
Translate Bio (TBIO) United States $0.490B 0.00
ChemoCentryx (CCXI) United States $0.481B 0.00
Dermira (DERM) United States $0.458B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.453B 22.86
Catalyst Pharmaceuticals (CPRX) United States $0.452B 0.00
Akebia Therapeutics (AKBA) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.445B 1.05
Dova Pharmaceuticals (DOVA) United States $0.440B 0.00
GlycoMimetics (GLYC) United States $0.422B 0.00
CV Sciences (CVSI) United States $0.410B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.406B 0.00
Flexion Therapeutics (FLXN) United States $0.401B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
Indivior (INVVY) United States $0.392B 1.42
CannTrust Holdings (CTST) Canada $0.386B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.370B 0.00
Harpoon Therapeutics (HARP) United States $0.365B 0.00
Xeris Pharmaceuticals (XERS) United States $0.345B 0.00
ImmunoGen (IMGN) United States $0.342B 0.00
Collegium Pharmaceutical (COLL) United States $0.339B 0.00
Lannett Co Inc (LCI) United States $0.331B 3.21
KalVista Pharmaceuticals (KALV) United States $0.319B 0.00
Rafael Holdings (RFL) United States $0.297B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.274B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
OptiNose (OPTN) United States $0.241B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.232B 0.00
Recro Pharma (REPH) United States $0.220B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.212B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.196B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 56.38
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Calithera Biosciences (CALA) United States $0.162B 0.00
DURECT (DRRX) United States $0.158B 0.00
Ardelyx (ARDX) United States $0.149B 0.00
IMV INC (IMV) Canada $0.147B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.146B 0.00
Jounce Therapeutics (JNCE) United States $0.137B 0.00
MEI Pharma (MEIP) United States $0.126B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.122B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.119B 0.00
Majesco Entertainment (PTE) United States $0.111B 0.00
Generex Biotechnology (GNBT) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.101B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
MediWound (MDWD) Israel $0.100B 0.00
RENEURON GP (RNUGF) United Kingdom $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Infinity Pharmaceuticals (INFI) United States $0.095B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
Mast Therapeutics (SVRA) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 62.89
Genocea Biosciences (GNCA) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.087B 748.00
Nivalis Therapeutics (ALPN) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Capnia (SLNO) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.080B 7.95
Cardiome Pharma (CORV) Canada $0.078B 0.00
China SXT Pharmaceuticals (SXTC) China $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.071B 0.00
Novan (NOVN) United States $0.069B 0.00
Pharmaxis (PXSLY) Australia $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.066B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.055B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
India Globalization Capital (IGC) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 0.00
Melinta Therapeutics (MLNT) United States $0.047B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
Biomerica (BMRA) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 1.40
Cyanotech (CYAN) United States $0.016B 0.00
Shineco (TYHT) China $0.015B 0.00
HANCOCK JAFFE (HJLI) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00